Search Results - Charpentier, Charlotte

Refine Results
  1. 1
    Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

    Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy by Charpentier, Charlotte, Weiss, Laurence

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations

    Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations by Charpentier, Charlotte, Descamps, Diane

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Extensive Recombination among Human Immunodeficiency Virus Type 1 Quasispecies Makes an Important Contribution to Viral Diversity in Individual Patients

    Extensive Recombination among Human Immunodeficiency Virus Type 1 Quasispecies Makes an Important Contribution to Viral Diversity in Individual Patients by Charpentier, Charlotte, Nora, Tamara, Tenaillon, Olivier, Clavel, François, Hance, Allan J.

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment

    Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment by Marcelin, Anne-Genevieve, Charpentier, Charlotte, Wirden, Marc, Descamps, Diane, Calvez, Vincent

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment

    Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment by Nora, Tamara, Charpentier, Charlotte, Tenaillon, Olivier, Hoede, Claire, Clavel, François, Hance, Allan J.

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Pre-clinical development as microbicide of zinc tetra-ascorbo-camphorate, a novel terpenoid derivative: Potent in vitro inhibitory activity against both R5- and X4-tropic HIV-1 strains without significant in vivo mucosal toxicity

    Pre-clinical development as microbicide of zinc tetra-ascorbo-camphorate, a novel terpenoid derivative: Potent in vitro inhibitory activity against both R5- and X4-tropic HIV-1 str... by Saïdi, Héla, Jenabian, Mohammad-Ali, Gombert, Bernard, Charpentier, Charlotte, Mannarini, Aurèle, Bélec, Laurent

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure

    Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure by Fransen, Signe, Karmochkine, Marina, Huang, Wei, Weiss, Laurence, Petropoulos, Christos J., Charpentier, Charlotte

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Role of Minority Populations of Human Immunodeficiency Virus Type 1 in the Evolution of Viral Resistance to Protease Inhibitors

    Role of Minority Populations of Human Immunodeficiency Virus Type 1 in the Evolution of Viral Resistance to Protease Inhibitors by Charpentier, Charlotte, Dwyer, Dominic E., Mammano, Fabrizio, Lecossier, Denise, Clavel, François, Hance, Allan J.

    Published 2004
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Omicron SARS-CoV-2 variant: What we know and what we don’t

    Omicron SARS-CoV-2 variant: What we know and what we don’t by Ferré, Valentine Marie, Peiffer-Smadja, Nathan, Visseaux, Benoit, Descamps, Diane, Ghosn, Jade, Charpentier, Charlotte

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses

    Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses by Nora, Tamara, Bouchonnet, Francine, Labrosse, Béatrice, Charpentier, Charlotte, Mammano, Fabrizio, Clavel, François, Hance, Allan J

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    PD-1/PD-L1 expression in anal squamous intraepithelial lesions

    PD-1/PD-L1 expression in anal squamous intraepithelial lesions by Bucau, Margot, Gault, Nathalie, Sritharan, Nanthara, Valette, Emy, Charpentier, Charlotte, Walker, Francine, Couvelard, Anne, Abramowitz, Laurent

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors

    Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors by Malet, Isabelle, Subra, Frédéric, Charpentier, Charlotte, Collin, Gilles, Descamps, Diane, Calvez, Vincent, Marcelin, Anne-Geneviève, Delelis, Olivier

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis

    No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis by Le Hingrat, Quentin, Ghanem, Mada, Cazes, Aurélie, Visseaux, Benoit, Collin, Gilles, Descamps, Diane, Charpentier, Charlotte, Crestani, Bruno

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to Raltegravir whereas Y143C does not

    G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to Raltegravir whereas Y143C does not by Ni, Xiao-Ju, Delelis, Olivier, Charpentier, Charlotte, Storto, Alexandre, Collin, Gilles, Damond, Florence, Descamps, Diane, Mouscadet, Jean-François

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d’Ivoire West Africa

    Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d’Ivoire West Africa by Tchounga, Boris K., Charpentier, Charlotte, Coffie, Patrick A., Dabis, François, Descamps, Diane, Eholie, Serge P., Ekouevi, Didier K.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”

    Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir” by Malet, Isabelle, Subra, Frédéric, Richetta, Clémence, Charpentier, Charlotte, Collin, Gilles, Descamps, Diane, Calvez, Vincent, Marcelin, Anne-Geneviève, Delelis, Olivier

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization

    Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization by Jenabian, Mohammad-Ali, Saïdi, Héla, Charpentier, Charlotte, Bouhlal, Hicham, Schols, Dominique, Balzarini, Jan, Bell, Thomas W, Vanham, Guido, Bélec, Laurent

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Distribution of HIV-1 and HSV-2 epidemics in Chad revealing HSV-2 hot-spot in regions of high-risk HIV spread

    Distribution of HIV-1 and HSV-2 epidemics in Chad revealing HSV-2 hot-spot in regions of high-risk HIV spread by Charpentier, Charlotte, Koyalta, Donato, Ndinaromtan, Montana, Tchobkréo, Bagamla, Jenabian, Mohammad-Ali, Day, Nesrine, Si-Mohamed, Ali, Weiss, Helen, Bélec, Laurent

    Published 2011
    Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

    Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study by Madelain, Vincent, Le, Minh, Champenois, Karen, Charpentier, Charlotte, Landman, Roland, Joly, Veronique, Yeni, Patrick, Descamps, Diane, Yazdanpanah, Yazdan, Peytavin, Gilles

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates

    Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates by Visseaux, Benoit, Charpentier, Charlotte, Collin, Gilles, Bertine, Mélanie, Peytavin, Gilles, Damond, Florence, Matheron, Sophie, Lefebvre, Eric, Brun-Vézinet, Françoise, Descamps, Diane

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: